Article Information
History
- May 31, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bethany Hicks1,*,
- Scott Jones1,
- Helen Callaby2,8,
- Daniel Bailey2,
- Claire Gordon2,
- Tommy Rampling2,
- Catherine Houlihan2,
- Ezra Linley7,
- Simon Tonge7,
- Clarissa Oeser6,
- Rachael Jones3,
- Marcus Pond4,
- Ravi Mehta4,
- Deborah Wright5,
- Bassam Hallis1,
- Cathy Rowe1 and
- Ashley Otter1
- 1Emerging Pathogen Serology Group, Vaccine Development Evaluation and Preparedness Centre, UK Health Security Agency, Porton Down, Wiltshire, UK
- 2Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down, Wiltshire, UK
- 3Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
- 4Imperial College Healthcare NHS Trust, London, UK
- 55Research and Development, UK Health Security Agency, Porton Down, Wiltshire, UK
- 6Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, Colindale, London, UK
- 7Seroepidemiology Unit, UK Health Security Agency, Manchester, UK
- 8The Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
- ↵*Corresponding author: bethany.hicks{at}ukhsa.gov.uk